More Competitors and Compatibility Opens Up Multi-Billion-Dollar Gene Expression...

More Competitors and Compatibility Opens Up Multi-Billion-Dollar Gene
Expression Analysis Market

NEW YORK, Jan. 15 /PRNewswire/ -- New products and applications have made
gene expression analysis a significantly more competitive market in the past
few years, which will lead to a market worth nearly $2.5 billion by 2012,
according to a new study released today from Kalorama Information. Real-time
PCR, improvements in microarrays, and the increasing reality of clinical
application beyond the research bench will propel double-digit growth in this
segment for the next 5 years, according to the study.
The new study, Gene Expression Profiling Markets, found that gene
expression analysis has progressed significantly in the past two years with
the emergence of a number of new techniques and technologies impacting the
market, including next-generation sequencers, SNP analysis, copy number
variation, methylation analysis, alternative splicing analysis, ChIP-on-chip,
and micro RNA technology. In addition, better standardization and
compatibility among technologies and increasing clarity regarding regulatory
issues are fueling healthy competition.
"The perception that the Affymetrix platform is the only reliable,
reproducible platform available is changing," notes Justin Saeks, analyst for
Kalorama Information and the author of the study. "Customers thought they
would never be able to compare legacy data with new data from other platforms;
however, it has now been demonstrated that these fears are not justified,
which has opened up the market to a host of new product introductions."
Kalorama Information's report Gene Expression Profiling Markets, provides
market forecasts through 2012 for microarrays, instruments and reagents, as
well as real-time PCR. It establishes competitive market share in gene
expression analysis, segments revenues regionally, identifies market
challenges, and discusses strategic recommendations for manufacturers. The
study also reviews new technologies available and in development, recent
business deals and alliances, progress on standardization and regulatory
guidance, and developments in new clinical applications just now emerging. The
report can be purchased directly from Kalorama Information by visiting
http://www.kaloramainformation.com/Gene-Expression-Profiling-1430119.
About Kalorama Information
Kalorama Information supplies the latest in independent market research on
medical markets. For more information, contact Tom Ehart at 240-747-3014 or
tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.
SOURCE Kalorama Information

Tom Ehart of MarketResearch.com, +1-240-747-3014, tehart@marketresearch.com,
for Kalorama Information